Perspective Therapeutics
CATX
27 hedge funds and large institutions have $3.71M invested in Perspective Therapeutics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
13% more funds holding
Funds holding: 24 → 27 (+3)
0.09% less ownership
Funds ownership: 7.85% → 7.76% (-0.09%)
35% less capital inflows, than outflows
Capital inflows: $86.1K | Capital outflows: $132K
86% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$27K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$23.2K |
| 3 |
SIA
Starfire Investment Advisers
Southfield,
Michigan
|
+$20.4K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$9.8K |
| 5 |
Financial Architects (New Jersey)
Marlton,
New Jersey
|
+$5.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$67.2K |
| 2 |
BlackRock Fund Advisors
San Francisco,
California
|
-$31.7K |
| 3 |
BlackRock Investment Management
Wilmington,
Delaware
|
-$9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.73K |
| 5 |
Virtu KCG Holdings
New York
|
-$5.96K |
CATX Hedge Fund Activity: Q2 2016 in Review
27 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2016, worth a combined $3.71M — down 4.5% from $3.89M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CATX positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 7 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $27K. The largest seller was Citadel Advisors, cutting an estimated $67.2K.
- 27 institutional investors held Perspective Therapeutics (CATX) as of Q2 2016, up from 24 in Q1 2016.
- Funds reported $3.71M of Perspective Therapeutics stock for Q2 2016, down 4.5% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q2 2016 and 1 closed out, a net change of +3 holders.
- The largest Perspective Therapeutics buyer in Q2 2016 was Susquehanna International Group, an estimated $27K added.
- The largest Perspective Therapeutics seller in Q2 2016 was Citadel Advisors, an estimated $67.2K sold.
Based on aggregated 13F filings for Q2 2016.